BAY207543 (Bepanthol, Bepantol® Derma Spray)
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Skin Recovery
Conditions
Skin Recovery
Trial Timeline
Feb 11, 2019 → Mar 11, 2019
NCT ID
NCT03853525About BAY207543 (Bepanthol, Bepantol® Derma Spray)
BAY207543 (Bepanthol, Bepantol® Derma Spray) is a approved stage product being developed by Bayer for Skin Recovery. The current trial status is completed. This product is registered under clinical trial identifier NCT03853525. Target conditions include Skin Recovery.
What happened to similar drugs?
15 of 20 similar drugs in Skin Recovery were approved
Approved (15) Terminated (4) Active (5)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03853512 | Approved | Completed |
| NCT03853525 | Approved | Completed |
| NCT03853538 | Approved | Completed |
Competing Products
20 competing products in Skin Recovery